Lacidipine for the treatment of arteriosclerosis
US5455257A · kind A · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 11, 1993 |
| Grant date | Oct 3, 1995 |
| Priority date | — |
| Expiry date | Aug 11, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a method for the treatment of arteriosclerosis in a mammal which comprises administering to said mammal an effective amount of (E)-4-[2-[3-(1,1-dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6- dimethyl-3,5-pyridinedicarboxylic acid diethyl ester, lacidipine, as well as methods of treatment of arteriosclerosis which comprise administering to a mammal, especially a human, in need thereof, a pharmaceutical composition comprising lacidipine and a pharmaceutically acceptable carrier or excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.